Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene

Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Hachisuka, Junichi, Doi, Kazuko, Moroi, Yoichi, Furue, Masutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: June 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130494/
https://www.ncbi.nlm.nih.gov/pubmed/21743808
http://dx.doi.org/10.1159/000329914
Descripción
Sumario:Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

Ejemplares similares